Minimus Spine careers

Triojection facilitates an injection of ozone gas to treat a herniated disc. It is already cleared for sale in Europe and Minimus is enrolling a multicenter, randomized study in Europe to compare outcomes between Triojection and surgery. Minimus is raising money to support a European launch.

Herniated discs are a common problem. Many are treated with epidural steroid injections and/or surgery. Steroid injections have limited benefit and are often repeated several times. Surgery is undesirable and associated with short and long term risks. Triojection can improve outcomes and save money.

There are over many peer reviewed studies of ozone being successfully for this indication. With 8 issued patents, Triojection minimizes the risk of infection and gives the doctor greater confidence in the concentration of ozone delivered to the patient.  Importantly, Triojection creates a new business model through the use of a sterile, single-use syringe cartridge to make ozone.